Optomed Oyj Statistics
Total Valuation
Optomed Oyj has a market cap or net worth of EUR 104.25 million. The enterprise value is 96.26 million.
Market Cap | 104.25M |
Enterprise Value | 96.26M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
Earnings Date | Aug 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Optomed Oyj has 19.60 million shares outstanding. The number of shares has increased by 13.01% in one year.
Shares Outstanding | 19.60M |
Shares Change (YoY) | +13.01% |
Shares Change (QoQ) | +2.35% |
Owned by Insiders (%) | 0.53% |
Owned by Institutions (%) | 54.92% |
Float | 14.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.37 |
PB Ratio | 3.81 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -19.84 |
EV / Sales | 6.54 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -98.13 |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 16.61.
Current Ratio | 3.16 |
Quick Ratio | 2.67 |
Debt / Equity | 16.61 |
Debt / EBITDA | n/a |
Debt / FCF | -4.20 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.56% and return on invested capital (ROIC) is -11.60%.
Return on Equity (ROE) | -22.56% |
Return on Assets (ROA) | -9.99% |
Return on Capital (ROIC) | -11.60% |
Revenue Per Employee | 133,727 |
Profits Per Employee | -44,118 |
Employee Count | 114 |
Asset Turnover | 0.48 |
Inventory Turnover | 1.69 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.90% in the last 52 weeks. The beta is 2.26, so Optomed Oyj's price volatility has been higher than the market average.
Beta (5Y) | 2.26 |
52-Week Price Change | +72.90% |
50-Day Moving Average | 5.61 |
200-Day Moving Average | 4.63 |
Relative Strength Index (RSI) | 50.60 |
Average Volume (20 Days) | 74,492 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Optomed Oyj had revenue of EUR 14.71 million and -4.85 million in losses. Loss per share was -0.28.
Revenue | 14.71M |
Gross Profit | 9.97M |
Operating Income | -4.94M |
Pretax Income | -4.92M |
Net Income | -4.85M |
EBITDA | -4.19M |
EBIT | -4.94M |
Loss Per Share | -0.28 |
Balance Sheet
The company has 12.11 million in cash and 4.12 million in debt, giving a net cash position of 7.98 million or 0.41 per share.
Cash & Cash Equivalents | 12.11M |
Total Debt | 4.12M |
Net Cash | 7.98M |
Net Cash Per Share | 0.41 |
Equity (Book Value) | 24.82M |
Book Value Per Share | 1.40 |
Working Capital | 11.86M |
Cash Flow
In the last 12 months, operating cash flow was -773,000 and capital expenditures -208,000, giving a free cash flow of -981,000.
Operating Cash Flow | -773,000 |
Capital Expenditures | -208,000 |
Free Cash Flow | -981,000 |
FCF Per Share | -0.05 |
Margins
Gross margin is 67.76%, with operating and profit margins of -33.56% and -32.99%.
Gross Margin | 67.76% |
Operating Margin | -33.56% |
Pretax Margin | -33.47% |
Profit Margin | -32.99% |
EBITDA Margin | -28.47% |
EBIT Margin | -33.56% |
FCF Margin | -6.67% |
Dividends & Yields
Optomed Oyj does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.01% |
Shareholder Yield | -13.01% |
Earnings Yield | -5.18% |
FCF Yield | -0.94% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |